{"id":"W2149270596","doi":"10.2147/pgpm.s55339","title":"Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer","year":2014,"lang":"en","type":"review","venue":"Pharmacogenomics and Personalized Medicine","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"Academy of Medical Sciences; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Afatinib; Medicine; Epidermal growth factor receptor; T790M; Lung cancer; Adenocarcinoma; EGFR inhibitors; Precision medicine; Drug resistance; Oncology; Targeted therapy; Osimertinib; Cancer research; Gefitinib; Cancer; Erlotinib; Internal medicine; Pathology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005608544,0.0007819833,0.002735317,0.0005639833,0.000132036,0.00002539714,0.0001471085,0.0002650924,0.0006455089],"category_scores_gemma":[0.00003425345,0.0004700743,0.0001828276,0.0004917136,0.0002600049,0.00008463065,0.00005080537,0.0005769214,0.000006734272],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007088275,"about_ca_system_score_gemma":0.0007426176,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001043009,"about_ca_topic_score_gemma":0.00009416018,"domain_scores_codex":[0.9970759,0.0001318284,0.001005405,0.0008754138,0.0004520108,0.0004594219],"domain_scores_gemma":[0.9983047,0.0002147039,0.0005284856,0.0002970976,0.0001674518,0.0004876225],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002941176,0.0002021499,0.0004209508,0.02922068,0.001144237,0.0001933652,0.005254408,0.000009559293,0.000863763,0.000044988,0.01046736,0.9518844],"study_design_scores_gemma":[0.01359743,0.000621336,0.00001570605,0.03054632,0.01261391,0.0001909336,0.0002292529,0.001318252,0.0000255058,0.000005465076,0.9403378,0.0004980691],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001973112,0.990154,0.0002374644,0.001778681,0.0007847234,0.003086221,0.00006203818,0.00003413952,0.00188961],"genre_scores_gemma":[0.001640731,0.9899992,0.0003062099,0.001078929,0.003446484,0.0006886195,0.001039807,0.0001403217,0.001659739],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9513863,"threshold_uncertainty_score":0.9997751,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09332858321314516,"score_gpt":0.4054736549770533,"score_spread":0.3121450717639082,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}